EC 5.1.3.8 | |
Антитело против CKMB | 9001-15-4 |
EC 3.1.1.1 | |
ЕС 3.2.1.30 | 9012-33-3 |
EC 3.4.19.3 | |
EC 2.6.1.18 | |
ЕС 3.4.24.4 | 9036-06-0 |
EC 3.4.24.18 | 148938-24-3 |
ЕС 3.5.4.3 | 9033-16-3 |
ЕС 1.4.3.14 | 70132-14-8 |
ЕС 1.1.1.40 | 9028-47-1 |
ЕС 2.7.7.9 | 9026-22-6 |
ЕС 3.3.2.3 | 9048-63-9 |
ЕС 3.4.15.1 | 9015-82-1 |
ЕС 1.1.1.67 | 9001-65-4 |
L-аминокислотная оксидаза | 9000-89-9 |
EC 1.13.11.34 | |
EC 2.6.1.36 | |
ЕС 3.1.1.3 | 9014-49-7 |
ЕС 1.1.3.21 | 9046-28-0 |
EC 2.4.1.17 | |
EC 1.11.1.13 | |
β-глюкуронидаза | 9001-45-0 |
ЕС 1.1.1.37 | 9001-64-3 |
ЕС 2.7.7.12 | 9016-11-9 |
EC-90 | |
EC3 | |
ЕС 1.4.1.9 | 9082-71-7 |
Lactic Dehydrogenase | 9001-60-9 |
Xanthine Oxidase | 9002-17-9 |
EC 4.2.2.8 | 149371-12-0 |
ЕС 3.4.14.1 | 9032-68-2 |
ЕС 3.2.1.49 | 9075-63-2 |
ЕС 1.11.1.10 | 9055-20-3 |
ЕС 3.5.2.10 | 9025-13-2 |
EC 4.1.2.5 | |
ЕС 1.1.1.28 | 9028-36-8 |
EC 3.4.24.17 | |
EC 2.7.11 | |
EC 1.5.1.3 | |
ЕС 3.1.4.3 | 9001-86-9 |
ЕС 1.2.1.2 | 9028-85-7 |
ЕС 5.3.2.1 | 9023-54-5 |
ЕС 1.1.1.2 | 9028-12-0 |
EC 1.6.8.1 | |
ЕС 5.4.2.2 | 9001-81-4 |
EC 2.1.1.8 | |
ЕС 3.1.1.7 | 9000-81-1 |
ЕС 6.4.1.1 | 9014-19-1 |
UDP-глюкоза-4-эпимераза EC #: 5.1.3.2 | 9032-89-7 |
EC 3.2.1.123 | |
EC 1.11.1.1 | |
polynucleotide phosphorylase | |
ЕС 3.4.13.9 | 9025-32-5 |
Фосфатаза, щелочная из телячьей кишки (CIP) grade II | 9001-78-9 |
EC 1.6.2.4 | |
ЕС 3.1.6.1 | 9016-17-5 |
EC 3.4.24.33 | 2392-42-9 |
(4E)-5-[[(3aS)-3,3aβ,4,5,6,6aβ-Hexahydro-5α-hydroxy-4β-[(1E,3S)-3-hydroxy-1-octenyl]pentalen]-2-yl]-4-pentenoic acid | |
5-[[(2E,3aS,6aα)-3,3a,4,5,6,6a-Hexahydro-5α-hydroxy-4β-[3-hydroxy-4-methyl-1-octenyl]pentalen]-2(1H)-ylidene]-5-cyanovaleric acid | |
5-[[(2E,3aS,6aα)-3,3a,4,5,6,6a-Hexahydro-5α-hydroxy-4β-[(E,S)-3-hydroxy-1-octenyl]pentalen]-2(1H)-ylidene]-5-cyanovaleric acid | |
Earlezzhlxys balanced salts (EBSS) with Phenol red | |
Earlezzhlxys balanced salts (EBSS) without Phenol red | |
(2E) -Δ2,2′-Bi [бензо [b] тиофен-3 (2H) -он] | 3844-31-3 |
Earle's Balanced Salt Solution without Sodium Bicarbonate
| |
Earle's Balanced Salt Solution w/o Phenol Red
| |
Earle’s Balanced Salts w/o CaCl2, MgSO4 (Modified) (Powder)
| |
Earle’s Balanced Salts w/o CaCl2, MgSO4, Phenol Red (Powder)
| |
Earle's Balanced Salt Solution 10-Fold Concentrate, w/o Phenol Red, w/o Sodium Bicarbonate
| |
Earle’s Balanced Salts (Powder)
| |
Earle’s Balanced Salts w/o CaCl2, MgSO4 (Powder)
| |
EARLE''S BALANCED SALTS (EBSS) WITH PHENOL RED | |
EARLE''S BALANCED SALTS (EBSS) WITHOUT PHENOL RED | |
EARLE''S BALANCED SALTS (EBSS) | |
EARLE''S BALANCED SALTS (EBSS) WITH 1 G/L D-GLUCOSE | |
EARLE''S BALANCED SALTS (EBSS) WITHOUT CALCIUM AND MAGNESIUM | |
Earle’s Balanced Salts w/o Phenol Red (Powder)
| |
Earle's Balanced Salt Solutionswithout Phenol Red & SodiumBicarbonate
| |
Earle's Balanced Salt Solution 10-Fold Concentrate w/o Sodium Bicarbonate
| |
Earle’s Balanced Salts (10X) (Powder)
| |
Earle’s Balanced Salts w/o MgSO4 (Powder)
| |
EARLGREYTEA | |
EARLI1 protein | |
(7E)-7-[[(3aS,6aS)-Tetrahydro-4-oxo-6β-[(E)-3-[[dimethyl(tert-butyl)silyl]oxy]-1-octenyl]-2,2-dimethyl-4H-cyclopenta-1,3-dioxol]-5-ylidene]heptanoic acid methyl ester | |
ЭБИДЕН | 71102-54-0 |
early placenta insulin-like peptide | |
ранний белок О, вирус псевдобешенства | 143891-25-2 |
early transcription factor, vaccinia | |
early growth response alpha | |
ранний белок, меченный цистеином | 147955-31-5 |
Early Mitotic Inhibitor 1 (Emi1, F-box Only Protein 5, Fbx5)
| |
EARLY GROWTH RESPONSE PROTEIN 1 (HUMAN) | |
EARLY GROWTH RESPONSE PROTEIN 3 (HUMAN) | |
EARLY GROWTH RESPONSE PROTEIN 4 (HUMAN) | |
Early-strength slushing agent for concrete | |
EarlyGrowthResponseProtein1(Egr1) | |
early-expressed protein 1 | |
белок ранней железы-1 | 147477-75-6 |
early mitotic inhibitor 1 | |
early light-inducible protein | |